查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1786990

Naltrexone·Buprenornhine(納曲酮和丁丙諾啡)市場，規模，佔有率，趨勢，產業分析報告:各產品，各給藥途徑，各用途，各流通管道，各地區-2025年～2034年市場預測

Naltrexone and Buprenorphine Market Size, Share, Trends, Industry Analysis Report By Product (Naltrexone, Buprenorphine), By Route of Administration, By Application, By Distribution Channel, By Region - Market Forecast, 2025-2034
出版日期: | 出版商: Polaris Market Research | 英文 129 Pages | 商品交期: 最快1-2個工作天內

價格

根據 Polaris Market Research 的最新研究，納曲酮和丁丙諾啡市場規模預計到 2034 年將達到 124 億美元。本報告深入分析了當前的市場動態，並分析了未來的市場成長。

納曲酮和丁丙諾啡是用於治療鴉片類藥物使用障礙的藥物，其作用是減少藥物渴求並預防復發。阿片類藥物使用疾患的治療正從短期戒毒轉向長期康復計畫。醫療保健專業人士認識到，持續的藥物治療可以改善康復效果並降低復發風險。納曲酮和丁丙諾啡均用於長期治療策略，因為它們可以維持治療參與度並降低復發的可能性。隨著越來越多的治療中心採用長期治療方案，對可以長期安全服用的藥物的需求也日益增長。這一趨勢支持在各種治療環境中持續使用這兩種藥物。

傳統上，阿片類藥物使用疾患的治療主要由成癮專家提供，但這種情況正在改變。現在，越來越多的初級保健提供者和全科醫生提供納曲酮和丁丙諾啡的藥物輔助治療。這部分歸功於處方限制的放寬以及對非專科醫生培訓的加強。現在患者可以從他們的常規醫生那裡接受治療，這使得治療更容易獲得。這種轉變有助於將鴉片類藥物使用障礙 (OUD) 治療納入常規醫療保健，從而增加能夠開始並繼續接受治療的患者數量。隨著可近性越來越廣泛，預計這些藥物的使用將繼續增加。

納曲酮與丁丙諾啡市場報告重點

到2024年，丁丙諾啡市場將佔據顯著佔有率，因為它廣泛應用於控制阿片類藥物戒斷症狀和減少藥物渴求。

預計在預測期內，醫院藥局市場將大幅成長，因為它是藥物過量和戒斷症狀患者的第一個護理點。

到2024年，北美將佔據納曲酮和丁丙諾啡市場的最大佔有率，這得益於阿片類藥物使用障礙的高發病率以及政府對擴大治療可及性的堅定承諾。

由於人們對物質使用障礙的認識不斷提高以及加強精神衛生服務的力度，亞太地區的納曲酮和丁丙諾啡市場正在經歷顯著增長。

全球主要市場參與者包括 Alkermes, Inc.、Camurus、Collegium Pharmaceutical、Indivior PLC、Orexo US, Inc.（Orexo AB 的子公司）、Sun Pharmaceutical Industries Ltd. 和 Titan Pharmaceuticals, Inc.。

目錄

第1章 簡介

第2章 摘要整理

第3章 調查手法

第4章 全球Naltrexone·Buprenornhine市場洞察

  • 市場概述
  • Naltrexone·Buprenornhine的市場動態
    • 促進因素和機會
      • 類鴉片物質使用障礙患者的增加
      • 政府的輔助政策與計劃
    • 阻礙因素與課題
      • 初期投資額提高
  • PESTEL分析
  • Naltrexone·Buprenornhine的市場趨勢
  • 價值鏈分析

第5章 全球Naltrexone·Buprenornhine市場:各產品

  • 主要調查結果
  • 簡介
  • Naltrexone
  • Buprenornhine

第6章 全球Naltrexone·Buprenornhine市場:各給藥途徑

  • 主要調查結果
  • 簡介
  • 口服給藥
  • 注射劑給藥
  • 置入式給藥

第7章 全球Naltrexone·Buprenornhine市場:各用途

  • 主要調查結果
  • 簡介
  • 類鴉片物質使用障礙(OUD)
  • 酒精使用障礙(AUD)

第8章 全球Naltrexone·Buprenornhine市場:各流通管道

  • 主要調查結果
  • 簡介
  • 醫院藥局
  • 零售藥局
  • 其他

第9章 全球Naltrexone·Buprenornhine市場:各地區

  • 主要調查結果
  • 簡介
    • Naltrexone·Buprenornhine的市場評估:地區，2020年～2034年
  • 北美
    • 北美:各產品，2020年～2034年
    • 北美:各給藥途徑，2020年～2034年
    • 北美:各用途，2020年～2034年
    • 北美:各流通管道，2020年～2034年
    • 美國
    • 加拿大
  • 歐洲
    • 歐洲:各產品，2020年～2034年
    • 歐洲:各給藥途徑，2020年～2034年
    • 歐洲:各用途，2020年～2034年
    • 歐洲:各流通管道，2020年～2034年
    • 英國
    • 法國
    • 德國
    • 義大利
    • 西班牙
    • 荷蘭
    • 俄羅斯
    • 其他歐洲
  • 亞太地區
    • 亞太地區:各產品，2020年～2034年
    • 亞太地區:各給藥途徑，2020年～2034年
    • 亞太地區:各用途，2020年～2034年
    • 亞太地區:各流通管道，2020年～2034年
    • 中國
    • 印度
    • 馬來西亞
    • 日本
    • 印尼
    • 韓國
    • 澳洲
    • 其他的亞太地區
  • 中東·非洲
    • 中東·非洲:各產品，2020年～2034年
    • 中東·非洲:各給藥途徑，2020年～2034年
    • 中東·非洲:各用途，2020年～2034年
    • 中東·非洲:各流通管道，2020年～2034年
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 南非
    • 其他中東·非洲
  • 南美
    • 南美:各產品，2020年～2034年
    • 南美:各給藥途徑，2020年～2034年
    • 南美:各用途，2020年～2034年
    • 南美:各流通管道，2020年～2034年
    • 墨西哥
    • 巴西
    • 阿根廷
    • 其他南美國家

第10章 競爭情形

  • 擴大和收購的分析
    • 擴大
    • 收購
  • 聯盟/合作/協定/公開

第11章 企業簡介

  • Alkermes, Inc.
  • Camurus
  • Collegium Pharmaceutical
  • Indivior PLC
  • Orexo US, Inc.(a part of Orexo AB)
  • Sun Pharmaceutical Industries Ltd
  • Titan Pharmaceuticals, Inc.
Product Code: PM5962

The naltrexone and buprenorphine market size is expected to reach USD 12.40 billion by 2034, according to a new study by Polaris Market Research. The report "Naltrexone and Buprenorphine Market Size, Share, Trends, Industry Analysis Report By Product (Naltrexone, Buprenorphine), By Route of Administration, By Application, By Distribution Channel, By Region- Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Naltrexone and buprenorphine are medications used to treat opioid use disorder by reducing cravings and preventing relapse. There is a shift in how opioid use disorder is being treated from short-term detox to long-term recovery planning. Healthcare professionals now recognize that continued medication support can improve recovery outcomes and lower relapse risks. Naltrexone and buprenorphine are both used in long-term treatment strategies because they help people stay engaged in care and reduce the chance of returning to drug use. As more treatment centers adopt a long-term approach, the need for medications that can be taken safely over time increases. This trend supports continued growth in the use of both medications across various care settings.

Traditionally, treatment for opioid use disorder was handled mostly by addiction specialists, but this is changing. Now, more primary care providers and general practitioners are offering medication-assisted treatment using naltrexone and buprenorphine. This is partly due to reduced prescribing restrictions and increased training for non-specialists. Patients can now receive treatment from their regular doctors, making it easier to access care. This shift is helping integrate OUD treatment into everyday healthcare, which increases the number of patients who can start and continue treatment. As access widens, use of these medications is expected to keep rising.

Naltrexone and Buprenorphine Market Report Highlights

In 2024, the buprenorphine segment dominated with a larger share due to its widespread use in managing opioid withdrawal symptoms and reducing cravings.

The hospitals pharmacies segment is expected to experience significant growth during the forecast period, as hospitals are the first point of care for individuals experiencing overdose or withdrawal.

In 2024, North America dominated the naltrexone and buprenorphine market with the largest share driven by the high prevalence of opioid use disorder and strong government involvement in expanding access to treatment.

The Asia Pacific naltrexone and buprenorphine market is experiencing significant growth, due to growing awareness of substance use disorders and efforts to strengthen mental health services.

A few global key market players are Alkermes, Inc.; Camurus; Collegium Pharmaceutical; Indivior PLC; Orexo US, Inc. (a part of Orexo AB); Sun Pharmaceutical Industries Ltd; and Titan Pharmaceuticals, Inc.

Polaris market research has segmented the naltrexone and buprenorphine market report based on product, route of administration, application, distribution channel, and region:

By Product (Revenue - USD Billion, 2020-2034)

Naltrexone

Buprenorphine

BELBUCA

Sublocade

Suboxone

Zubsolv

Others

By Route of Administration (Revenue - USD Billion, 2020-2034)

Oral Administration

Injectable Administration

Implantable Administration

By Application (Revenue - USD Billion, 2020-2034)

Opioid Use Disorder (OUD)

Alcohol Use Disorder (AUD)

By Distribution Channel (Revenue - USD Billion, 2020-2034)

Hospitals Pharmacies

Retail Pharmacies

Others

By Regional Outlook (Revenue - USD Billion, 2020-2034)

North America

U.S.

Canada

Mexico

Europe

Germany

UK

France

Italy

Spain

Russia

Netherlands

Rest of Europe

Asia Pacific

China

India

Japan

South Korea

Indonesia

Malaysia

Australia

Rest of APAC

Latin America

Argentina

Brazil

Rest of Latin America

Middle East & Africa

UAE

Saudi Arabia

Israel

South Africa

Rest of MEA

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Naltrexone And Buprenorphine Market Insights

  • 4.1. Naltrexone And Buprenorphine Market - Market Snapshot
  • 4.2. Naltrexone And Buprenorphine Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Growing Number of People with Opioid Use Disorder
      • 4.2.1.2. Supportive Government Policies and Programs
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. High Initial Investment
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Naltrexone And Buprenorphine Market Trends
  • 4.6. Value Chain Analysis

5. Global Naltrexone And Buprenorphine Market, by Product

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Naltrexone And Buprenorphine Market, by Product, 2020-2034 (USD billion)
  • 5.3. Naltrexone
    • 5.3.1. Global Naltrexone And Buprenorphine Market, by Naltrexone, by Region, 2020-2034 (USD billion)
  • 5.4. Buprenorphine
    • 5.4.1. Global Naltrexone And Buprenorphine Market, by Buprenorphine, by Region, 2020-2034 (USD billion)
    • 5.4.2. BELBUCA
      • 5.4.2.1. Global Naltrexone And Buprenorphine Market, by BELBUCA, by Region, 2020-2034 (USD billion)
    • 5.4.3. Sublocade
      • 5.4.3.1. Global Naltrexone And Buprenorphine Market, by Sublocade, by Region, 2020-2034 (USD billion)
    • 5.4.4. Suboxone
      • 5.4.4.1. Global Naltrexone And Buprenorphine Market, by Suboxone, by Region, 2020-2034 (USD billion)
    • 5.4.5. Zubsolv
      • 5.4.5.1. Global Naltrexone And Buprenorphine Market, by Zubsolv, by Region, 2020-2034 (USD billion)
    • 5.4.6. Others
      • 5.4.6.1. Global Naltrexone And Buprenorphine Market, by Others, by Region, 2020-2034 (USD billion)

6. Global Naltrexone And Buprenorphine Market, by Route of Administration

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Naltrexone And Buprenorphine Market, by Route of Administration, 2020-2034 (USD billion)
  • 6.3. Oral Administration
    • 6.3.1. Global Naltrexone And Buprenorphine Market, by Oral Administration, by Region, 2020-2034 (USD billion)
  • 6.4. Injectable Administration
    • 6.4.1. Global Naltrexone And Buprenorphine Market, by Injectable Administration, by Region, 2020-2034 (USD billion)
  • 6.5. Implantable Administration
    • 6.5.1. Global Naltrexone And Buprenorphine Market, by Implantable Administration, by Region, 2020-2034 (USD billion)

7. Global Naltrexone And Buprenorphine Market, by Application

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Naltrexone And Buprenorphine Market, by Medical Biotechnology, 2020-2034 (USD billion)
  • 7.3. Opioid use disorder (OUD)
    • 7.3.1. Global Naltrexone And Buprenorphine Market, by Opioid use disorder (OUD), by Region, 2020-2034 (USD billion)
  • 7.4. Alcohol use disorder (AUD)
    • 7.4.1. Global Naltrexone And Buprenorphine Market, by Alcohol use disorder (AUD), by Region, 2020-2034 (USD billion)

8. Global Naltrexone And Buprenorphine Market, by Distribution Channel

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Global Naltrexone And Buprenorphine Market, by Distribution Channel, 2020-2034 (USD billion)
  • 8.3. Hospitals Pharmacies
    • 8.3.1. Global Naltrexone And Buprenorphine Market, by Hospitals Pharmacies, by Region, 2020-2034 (USD billion)
  • 8.4. Retail Pharmacies
    • 8.4.1. Global Naltrexone And Buprenorphine Market, by Retail Pharmacies, by Region, 2020-2034 (USD billion)
  • 8.5. Others
    • 8.5.1. Global Naltrexone And Buprenorphine Market, by Others, by Region, 2020-2034 (USD billion)

9. Global Naltrexone And Buprenorphine Market, by Geography

  • 9.1. Key Findings
  • 9.2. Introduction
    • 9.2.1. Naltrexone And Buprenorphine Market Assessment, By Geography, 2020-2034 (USD billion)
  • 9.3. Naltrexone And Buprenorphine Market - North America
    • 9.3.1. North America: Naltrexone And Buprenorphine Market, by Product, 2020-2034 (USD billion)
    • 9.3.2. North America: Naltrexone And Buprenorphine Market, by Route of Administration, 2020-2034 (USD billion)
    • 9.3.3. North America: Naltrexone And Buprenorphine Market, by Application, 2020-2034 (USD billion)
    • 9.3.4. North America: Naltrexone And Buprenorphine Market, by Distribution Channel, 2020-2034 (USD billion)
    • 9.3.5. Naltrexone And Buprenorphine Market - US
      • 9.3.5.1. US: Naltrexone And Buprenorphine Market, by Product, 2020-2034 (USD billion)
      • 9.3.5.2. US: Naltrexone And Buprenorphine Market, by Route of Administration, 2020-2034 (USD billion)
      • 9.3.5.3. US: Naltrexone And Buprenorphine Market, by Application, 2020-2034 (USD billion)
      • 9.3.5.4. US: Naltrexone And Buprenorphine Market, by Distribution Channel, 2020-2034 (USD billion)
    • 9.3.6. Naltrexone And Buprenorphine Market - Canada
      • 9.3.6.1. Canada: Naltrexone And Buprenorphine Market, by Product, 2020-2034 (USD billion)
      • 9.3.6.2. Canada: Naltrexone And Buprenorphine Market, by Route of Administration, 2020-2034 (USD billion)
      • 9.3.6.3. Canada: Naltrexone And Buprenorphine Market, by Application, 2020-2034 (USD billion)
      • 9.3.6.4. Canada: Naltrexone And Buprenorphine Market, by Distribution Channel, 2020-2034 (USD billion)
  • 9.4. Naltrexone And Buprenorphine Market - Europe
    • 9.4.1. Europe: Naltrexone And Buprenorphine Market, by Product, 2020-2034 (USD billion)
    • 9.4.2. Europe: Naltrexone And Buprenorphine Market, by Route of Administration, 2020-2034 (USD billion)
    • 9.4.3. Europe: Naltrexone And Buprenorphine Market, by Application, 2020-2034 (USD billion)
    • 9.4.4. Europe: Naltrexone And Buprenorphine Market, by Distribution Channel, 2020-2034 (USD billion)
    • 9.4.5. Naltrexone And Buprenorphine Market - UK
      • 9.4.5.1. UK: Naltrexone And Buprenorphine Market, by Product, 2020-2034 (USD billion)
      • 9.4.5.2. UK: Naltrexone And Buprenorphine Market, by Route of Administration, 2020-2034 (USD billion)
      • 9.4.5.3. UK: Naltrexone And Buprenorphine Market, by Application, 2020-2034 (USD billion)
      • 9.4.5.4. UK: Naltrexone And Buprenorphine Market, by Distribution Channel, 2020-2034 (USD billion)
    • 9.4.6. Naltrexone And Buprenorphine Market - France
      • 9.4.6.1. France: Naltrexone And Buprenorphine Market, by Product, 2020-2034 (USD billion)
      • 9.4.6.2. France: Naltrexone And Buprenorphine Market, by Route of Administration, 2020-2034 (USD billion)
      • 9.4.6.3. France: Naltrexone And Buprenorphine Market, by Application, 2020-2034 (USD billion)
      • 9.4.6.4. France: Naltrexone And Buprenorphine Market, by Distribution Channel, 2020-2034 (USD billion)
    • 9.4.7. Naltrexone And Buprenorphine Market - Germany
      • 9.4.7.1. Germany: Naltrexone And Buprenorphine Market, by Product, 2020-2034 (USD billion)
      • 9.4.7.2. Germany: Naltrexone And Buprenorphine Market, by Route of Administration, 2020-2034 (USD billion)
      • 9.4.7.3. Germany: Naltrexone And Buprenorphine Market, by Application, 2020-2034 (USD billion)
      • 9.4.7.4. Germany: Naltrexone And Buprenorphine Market, by Distribution Channel, 2020-2034 (USD billion)
    • 9.4.8. Naltrexone And Buprenorphine Market - Italy
      • 9.4.8.1. Italy: Naltrexone And Buprenorphine Market, by Product, 2020-2034 (USD billion)
      • 9.4.8.2. Italy: Naltrexone And Buprenorphine Market, by Route of Administration, 2020-2034 (USD billion)
      • 9.4.8.3. Italy: Naltrexone And Buprenorphine Market, by Application, 2020-2034 (USD billion)
      • 9.4.8.4. Italy: Naltrexone And Buprenorphine Market, by Distribution Channel, 2020-2034 (USD billion)
    • 9.4.9. Naltrexone And Buprenorphine Market - Spain
      • 9.4.9.1. Spain: Naltrexone And Buprenorphine Market, by Product, 2020-2034 (USD billion)
      • 9.4.9.2. Spain: Naltrexone And Buprenorphine Market, by Route of Administration, 2020-2034 (USD billion)
      • 9.4.9.3. Spain: Naltrexone And Buprenorphine Market, by Application, 2020-2034 (USD billion)
      • 9.4.9.4. Spain: Naltrexone And Buprenorphine Market, by Distribution Channel, 2020-2034 (USD billion)
    • 9.4.10. Naltrexone And Buprenorphine Market - Netherlands
      • 9.4.10.1. Netherlands: Naltrexone And Buprenorphine Market, by Product, 2020-2034 (USD billion)
      • 9.4.10.2. Netherlands: Naltrexone And Buprenorphine Market, by Route of Administration, 2020-2034 (USD billion)
      • 9.4.10.3. Netherlands: Naltrexone And Buprenorphine Market, by Application, 2020-2034 (USD billion)
      • 9.4.10.4. Netherlands: Naltrexone And Buprenorphine Market, by Distribution Channel, 2020-2034 (USD billion)
    • 9.4.11. Naltrexone And Buprenorphine Market - Russia
      • 9.4.11.1. Russia: Naltrexone And Buprenorphine Market, by Product, 2020-2034 (USD billion)
      • 9.4.11.2. Russia: Naltrexone And Buprenorphine Market, by Route of Administration, 2020-2034 (USD billion)
      • 9.4.11.3. Russia: Naltrexone And Buprenorphine Market, by Application, 2020-2034 (USD billion)
      • 9.4.11.4. Russia: Naltrexone And Buprenorphine Market, by Distribution Channel, 2020-2034 (USD billion)
    • 9.4.12. Naltrexone And Buprenorphine Market - Rest of Europe
      • 9.4.12.1. Rest of Europe: Naltrexone And Buprenorphine Market, by Product, 2020-2034 (USD billion)
      • 9.4.12.2. Rest of Europe: Naltrexone And Buprenorphine Market, by Route of Administration, 2020-2034 (USD billion)
      • 9.4.12.3. Rest of Europe: Naltrexone And Buprenorphine Market, by Application, 2020-2034 (USD billion)
      • 9.4.12.4. Rest of Europe: Naltrexone And Buprenorphine Market, by Distribution Channel, 2020-2034 (USD billion)
  • 9.5. Naltrexone And Buprenorphine Market - Asia Pacific
    • 9.5.1. Asia Pacific: Naltrexone And Buprenorphine Market, by Product, 2020-2034 (USD billion)
    • 9.5.2. Asia Pacific: Naltrexone And Buprenorphine Market, by Route of Administration, 2020-2034 (USD billion)
    • 9.5.3. Asia Pacific: Naltrexone And Buprenorphine Market, by Application, 2020-2034 (USD billion)
    • 9.5.4. Asia Pacific: Naltrexone And Buprenorphine Market, by Distribution Channel, 2020-2034 (USD billion)
    • 9.5.5. Naltrexone And Buprenorphine Market - China
      • 9.5.5.1. China: Naltrexone And Buprenorphine Market, by Product, 2020-2034 (USD billion)
      • 9.5.5.2. China: Naltrexone And Buprenorphine Market, by Route of Administration, 2020-2034 (USD billion)
      • 9.5.5.3. China: Naltrexone And Buprenorphine Market, by Application, 2020-2034 (USD billion)
      • 9.5.5.4. China: Naltrexone And Buprenorphine Market, by Distribution Channel, 2020-2034 (USD billion)
    • 9.5.6. Naltrexone And Buprenorphine Market - India
      • 9.5.6.1. India: Naltrexone And Buprenorphine Market, by Product, 2020-2034 (USD billion)
      • 9.5.6.2. India: Naltrexone And Buprenorphine Market, by Route of Administration, 2020-2034 (USD billion)
      • 9.5.6.3. India: Naltrexone And Buprenorphine Market, by Application, 2020-2034 (USD billion)
      • 9.5.6.4. India: Naltrexone And Buprenorphine Market, by Distribution Channel, 2020-2034 (USD billion)
    • 9.5.7. Naltrexone And Buprenorphine Market - Malaysia
      • 9.5.7.1. Malaysia: Naltrexone And Buprenorphine Market, by Product, 2020-2034 (USD billion)
      • 9.5.7.2. Malaysia: Naltrexone And Buprenorphine Market, by Route of Administration, 2020-2034 (USD billion)
      • 9.5.7.3. Malaysia: Naltrexone And Buprenorphine Market, by Application, 2020-2034 (USD billion)
      • 9.5.7.4. Malaysia: Naltrexone And Buprenorphine Market, by Distribution Channel, 2020-2034 (USD billion)
    • 9.5.8. Naltrexone And Buprenorphine Market - Japan
      • 9.5.8.1. Japan: Naltrexone And Buprenorphine Market, by Product, 2020-2034 (USD billion)
      • 9.5.8.2. Japan: Naltrexone And Buprenorphine Market, by Route of Administration, 2020-2034 (USD billion)
      • 9.5.8.3. Japan: Naltrexone And Buprenorphine Market, by Application, 2020-2034 (USD billion)
      • 9.5.8.4. Japan: Naltrexone And Buprenorphine Market, by Distribution Channel, 2020-2034 (USD billion)
    • 9.5.9. Naltrexone And Buprenorphine Market - Indonesia
      • 9.5.9.1. Indonesia: Naltrexone And Buprenorphine Market, by Product, 2020-2034 (USD billion)
      • 9.5.9.2. Indonesia: Naltrexone And Buprenorphine Market, by Route of Administration, 2020-2034 (USD billion)
      • 9.5.9.3. Indonesia: Naltrexone And Buprenorphine Market, by Application, 2020-2034 (USD billion)
      • 9.5.9.4. Indonesia: Naltrexone And Buprenorphine Market, by Distribution Channel, 2020-2034 (USD billion)
    • 9.5.10. Naltrexone And Buprenorphine Market - South Korea
      • 9.5.10.1. South Korea: Naltrexone And Buprenorphine Market, by Product, 2020-2034 (USD billion)
      • 9.5.10.2. South Korea: Naltrexone And Buprenorphine Market, by Route of Administration, 2020-2034 (USD billion)
      • 9.5.10.3. South Korea: Naltrexone And Buprenorphine Market, by Application, 2020-2034 (USD billion)
      • 9.5.10.4. South Korea: Naltrexone And Buprenorphine Market, by Distribution Channel, 2020-2034 (USD billion)
    • 9.5.11. Naltrexone And Buprenorphine Market - Australia
      • 9.5.11.1. Australia: Naltrexone And Buprenorphine Market, by Product, 2020-2034 (USD billion)
      • 9.5.11.2. Australia: Naltrexone And Buprenorphine Market, by Route of Administration, 2020-2034 (USD billion)
      • 9.5.11.3. Australia: Naltrexone And Buprenorphine Market, by Application, 2020-2034 (USD billion)
      • 9.5.11.4. Australia: Naltrexone And Buprenorphine Market, by Distribution Channel, 2020-2034 (USD billion)
    • 9.5.12. Naltrexone And Buprenorphine Market - Rest of Asia Pacific
      • 9.5.12.1. Rest of Asia Pacific: Naltrexone And Buprenorphine Market, by Product, 2020-2034 (USD billion)
      • 9.5.12.2. Rest of Asia Pacific: Naltrexone And Buprenorphine Market, by Route of Administration, 2020-2034 (USD billion)
      • 9.5.12.3. Rest of Asia Pacific: Naltrexone And Buprenorphine Market, by Application, 2020-2034 (USD billion)
      • 9.5.12.4. Rest of Asia Pacific: Naltrexone And Buprenorphine Market, by Distribution Channel, 2020-2034 (USD billion)
  • 9.6. Naltrexone And Buprenorphine Market - Middle East & Africa
    • 9.6.1. Middle East & Africa: Naltrexone And Buprenorphine Market, by Product, 2020-2034 (USD billion)
    • 9.6.2. Middle East & Africa: Naltrexone And Buprenorphine Market, by Route of Administration, 2020-2034 (USD billion)
    • 9.6.3. Middle East & Africa: Naltrexone And Buprenorphine Market, by Application, 2020-2034 (USD billion)
    • 9.6.4. Middle East & Africa: Naltrexone And Buprenorphine Market, by Distribution Channel, 2020-2034 (USD billion)
    • 9.6.5. Naltrexone And Buprenorphine Market - Saudi Arabia
      • 9.6.5.1. Saudi Arabia: Naltrexone And Buprenorphine Market, by Product, 2020-2034 (USD billion)
      • 9.6.5.2. Saudi Arabia: Naltrexone And Buprenorphine Market, by Route of Administration, 2020-2034 (USD billion)
      • 9.6.5.3. Saudi Arabia: Naltrexone And Buprenorphine Market, by Application, 2020-2034 (USD billion)
      • 9.6.5.4. Saudi Arabia: Naltrexone And Buprenorphine Market, by Distribution Channel, 2020-2034 (USD billion)
    • 9.6.6. Naltrexone And Buprenorphine Market - UAE
      • 9.6.6.1. UAE: Naltrexone And Buprenorphine Market, by Product, 2020-2034 (USD billion)
      • 9.6.6.2. UAE: Naltrexone And Buprenorphine Market, by Route of Administration, 2020-2034 (USD billion)
      • 9.6.6.3. UAE: Naltrexone And Buprenorphine Market, by Application, 2020-2034 (USD billion)
      • 9.6.6.4. UAE: Naltrexone And Buprenorphine Market, by Distribution Channel, 2020-2034 (USD billion)
    • 9.6.7. Naltrexone And Buprenorphine Market - Israel
      • 9.6.7.1. Israel: Naltrexone And Buprenorphine Market, by Product, 2020-2034 (USD billion)
      • 9.6.7.2. Israel: Naltrexone And Buprenorphine Market, by Route of Administration, 2020-2034 (USD billion)
      • 9.6.7.3. Israel: Naltrexone And Buprenorphine Market, by Application, 2020-2034 (USD billion)
      • 9.6.7.4. Israel: Naltrexone And Buprenorphine Market, by Distribution Channel, 2020-2034 (USD billion)
    • 9.6.8. Naltrexone And Buprenorphine Market - South Africa
      • 9.6.8.1. South Africa: Naltrexone And Buprenorphine Market, by Product, 2020-2034 (USD billion)
      • 9.6.8.2. South Africa: Naltrexone And Buprenorphine Market, by Route of Administration, 2020-2034 (USD billion)
      • 9.6.8.3. South Africa: Naltrexone And Buprenorphine Market, by Application, 2020-2034 (USD billion)
      • 9.6.8.4. South Africa: Naltrexone And Buprenorphine Market, by Distribution Channel, 2020-2034 (USD billion)
    • 9.6.9. Naltrexone And Buprenorphine Market - Rest of Middle East & Africa
      • 9.6.9.1. Rest of Middle East & Africa: Naltrexone And Buprenorphine Market, by Product, 2020-2034 (USD billion)
      • 9.6.9.2. Rest of Middle East & Africa: Naltrexone And Buprenorphine Market, by Route of Administration, 2020-2034 (USD billion)
      • 9.6.9.3. Rest of Middle East & Africa: Naltrexone And Buprenorphine Market, by Application, 2020-2034 (USD billion)
      • 9.6.9.4. Rest of Middle East & Africa: Naltrexone And Buprenorphine Market, by Distribution Channel, 2020-2034 (USD billion)
  • 9.7. Naltrexone And Buprenorphine Market - Latin America
    • 9.7.1. Latin America: Naltrexone And Buprenorphine Market, by Product, 2020-2034 (USD billion)
    • 9.7.2. Latin America: Naltrexone And Buprenorphine Market, by Route of Administration, 2020-2034 (USD billion)
    • 9.7.3. Latin America: Naltrexone And Buprenorphine Market, by Application, 2020-2034 (USD billion)
    • 9.7.4. Latin America: Naltrexone And Buprenorphine Market, by Distribution Channel, 2020-2034 (USD billion)
    • 9.7.5. Naltrexone And Buprenorphine Market - Mexico
      • 9.7.5.1. Mexico: Naltrexone And Buprenorphine Market, by Product, 2020-2034 (USD billion)
      • 9.7.5.2. Mexico: Naltrexone And Buprenorphine Market, by Route of Administration, 2020-2034 (USD billion)
      • 9.7.5.3. Mexico: Naltrexone And Buprenorphine Market, by Application, 2020-2034 (USD billion)
      • 9.7.5.4. Mexico: Naltrexone And Buprenorphine Market, by Distribution Channel, 2020-2034 (USD billion)
    • 9.7.6. Naltrexone And Buprenorphine Market - Brazil
      • 9.7.6.1. Brazil: Naltrexone And Buprenorphine Market, by Product, 2020-2034 (USD billion)
      • 9.7.6.2. Brazil: Naltrexone And Buprenorphine Market, by Route of Administration, 2020-2034 (USD billion)
      • 9.7.6.3. Brazil: Naltrexone And Buprenorphine Market, by Application, 2020-2034 (USD billion)
      • 9.7.6.4. Brazil: Naltrexone And Buprenorphine Market, by Distribution Channel, 2020-2034 (USD billion)
    • 9.7.7. Naltrexone And Buprenorphine Market - Argentina
      • 9.7.7.1. Argentina: Naltrexone And Buprenorphine Market, by Product, 2020-2034 (USD billion)
      • 9.7.7.2. Argentina: Naltrexone And Buprenorphine Market, by Route of Administration, 2020-2034 (USD billion)
      • 9.7.7.3. Argentina: Naltrexone And Buprenorphine Market, by Application, 2020-2034 (USD billion)
      • 9.7.7.4. Argentina: Naltrexone And Buprenorphine Market, by Distribution Channel, 2020-2034 (USD billion)
    • 9.7.8. Naltrexone And Buprenorphine Market - Rest of Latin America
      • 9.7.8.1. Rest of Latin America: Naltrexone And Buprenorphine Market, by Product, 2020-2034 (USD billion)
      • 9.7.8.2. Rest of Latin America: Naltrexone And Buprenorphine Market, by Route of Administration, 2020-2034 (USD billion)
      • 9.7.8.3. Rest of Latin America: Naltrexone And Buprenorphine Market, by Application, 2020-2034 (USD billion)
      • 9.7.8.4. Rest of Latin America: Naltrexone And Buprenorphine Market, by Distribution Channel, 2020-2034 (USD billion)

10. Competitive Landscape

  • 10.1. Expansion and Acquisition Analysis
    • 10.1.1. Expansion
    • 10.1.2. Acquisitions
  • 10.2. Partnerships/Collaborations/Agreements/Exhibitions

11. Company Profiles

  • 11.1. Alkermes, Inc.
    • 11.1.1. Company Overview
    • 11.1.2. Financial Performance
    • 11.1.3. Product Benchmarking
    • 11.1.4. Recent Development
  • 11.2. Camurus
    • 11.2.1. Company Overview
    • 11.2.2. Financial Performance
    • 11.2.3. Product Benchmarking
    • 11.2.4. Recent Development
  • 11.3. Collegium Pharmaceutical
    • 11.3.1. Company Overview
    • 11.3.2. Financial Performance
    • 11.3.3. Product Benchmarking
    • 11.3.4. Recent Development
  • 11.4. Indivior PLC
    • 11.4.1. Company Overview
    • 11.4.2. Financial Performance
    • 11.4.3. Product Benchmarking
    • 11.4.4. Recent Development
  • 11.5. Orexo US, Inc. (a part of Orexo AB)
    • 11.5.1. Company Overview
    • 11.5.2. Financial Performance
    • 11.5.3. Product Benchmarking
    • 11.5.4. Recent Development
  • 11.6. Sun Pharmaceutical Industries Ltd
    • 11.6.1. Company Overview
    • 11.6.2. Financial Performance
    • 11.6.3. Product Benchmarking
    • 11.6.4. Recent Development
  • 11.7. Titan Pharmaceuticals, Inc.
    • 11.7.1. Company Overview
    • 11.7.2. Financial Performance
    • 11.7.3. Product Benchmarking
    • 11.7.4. Recent Development

List of Tables:

  • Table 1 Global Naltrexone And Buprenorphine Market, by Product, 2020-2034 (USD billion)
  • Table 2 Global Naltrexone And Buprenorphine Market, by Route of Administration, 2020-2034 (USD billion)
  • Table 3 Global Naltrexone And Buprenorphine Market, by Application, 2020-2034 (USD billion)
  • Table 4 Global Naltrexone And Buprenorphine Market, by Distribution Channel, 2020-2034 (USD billion)
  • Table 5 North America: Naltrexone And Buprenorphine Market, by Product, 2020-2034 (USD billion)
  • Table 6 North America: Naltrexone And Buprenorphine Market, by Route of Administration, 2020-2034 (USD billion)
  • Table 7 North America: Naltrexone And Buprenorphine Market, by Application, 2020-2034 (USD billion)
  • Table 8 North America: Naltrexone And Buprenorphine Market, by Distribution Channel, 2020-2034 (USD billion)
  • Table 9 US: Naltrexone And Buprenorphine Market, by Product, 2020-2034 (USD billion)
  • Table 10 US: Naltrexone And Buprenorphine Market, by Route of Administration, 2020-2034 (USD billion)
  • Table 11 US: Naltrexone And Buprenorphine Market, by Application, 2020-2034 (USD billion)
  • Table 12 US: Naltrexone And Buprenorphine Market, by Distribution Channel, 2020-2034 (USD billion)
  • Table 13 Canada: Naltrexone And Buprenorphine Market, by Product, 2020-2034 (USD billion)
  • Table 14 Canada: Naltrexone And Buprenorphine Market, by Route of Administration, 2020-2034 (USD billion)
  • Table 15 Canada: Naltrexone And Buprenorphine Market, by Application, 2020-2034 (USD billion)
  • Table 16 Canada: Naltrexone And Buprenorphine Market, by Distribution Channel, 2020-2034 (USD billion)
  • Table 17 Europe: Naltrexone And Buprenorphine Market, by Product, 2020-2034 (USD billion)
  • Table 18 Europe: Naltrexone And Buprenorphine Market, by Route of Administration, 2020-2034 (USD billion)
  • Table 19 Europe: Naltrexone And Buprenorphine Market, by Application, 2020-2034 (USD billion)
  • Table 20 Europe: Naltrexone And Buprenorphine Market, by Distribution Channel, 2020-2034 (USD billion)
  • Table 21 UK: Naltrexone And Buprenorphine Market, by Product, 2020-2034 (USD billion)
  • Table 22 UK: Naltrexone And Buprenorphine Market, by Route of Administration, 2020-2034 (USD billion)
  • Table 23 UK: Naltrexone And Buprenorphine Market, by Application, 2020-2034 (USD billion)
  • Table 24 UK: Naltrexone And Buprenorphine Market, by Distribution Channel, 2020-2034 (USD billion)
  • Table 25 France: Naltrexone And Buprenorphine Market, by Product, 2020-2034 (USD billion)
  • Table 26 France: Naltrexone And Buprenorphine Market, by Route of Administration, 2020-2034 (USD billion)
  • Table 27 France: Naltrexone And Buprenorphine Market, by Application, 2020-2034 (USD billion)
  • Table 28 France: Naltrexone And Buprenorphine Market, by Distribution Channel, 2020-2034 (USD billion)
  • Table 29 Germany: Naltrexone And Buprenorphine Market, by Product, 2020-2034 (USD billion)
  • Table 30 Germany: Naltrexone And Buprenorphine Market, by Route of Administration, 2020-2034 (USD billion)
  • Table 31 Germany: Naltrexone And Buprenorphine Market, by Application, 2020-2034 (USD billion)
  • Table 32 Germany: Naltrexone And Buprenorphine Market, by Distribution Channel, 2020-2034 (USD billion)
  • Table 33 Italy: Naltrexone And Buprenorphine Market, by Product, 2020-2034 (USD billion)
  • Table 34 Italy: Naltrexone And Buprenorphine Market, by Route of Administration, 2020-2034 (USD billion)
  • Table 35 Italy: Naltrexone And Buprenorphine Market, by Application, 2020-2034 (USD billion)
  • Table 36 Italy: Naltrexone And Buprenorphine Market, by Distribution Channel, 2020-2034 (USD billion)
  • Table 37 Spain: Naltrexone And Buprenorphine Market, by Product, 2020-2034 (USD billion)
  • Table 38 Spain: Naltrexone And Buprenorphine Market, by Route of Administration, 2020-2034 (USD billion)
  • Table 39 Spain: Naltrexone And Buprenorphine Market, by Application, 2020-2034 (USD billion)
  • Table 40 Spain: Naltrexone And Buprenorphine Market, by Distribution Channel, 2020-2034 (USD billion)
  • Table 41 Netherlands: Naltrexone And Buprenorphine Market, by Product, 2020-2034 (USD billion)
  • Table 42 Netherlands: Naltrexone And Buprenorphine Market, by Route of Administration, 2020-2034 (USD billion)
  • Table 43 Netherlands: Naltrexone And Buprenorphine Market, by Application, 2020-2034 (USD billion)
  • Table 44 Netherlands: Naltrexone And Buprenorphine Market, by Distribution Channel, 2020-2034 (USD billion)
  • Table 45 Russia: Naltrexone And Buprenorphine Market, by Product, 2020-2034 (USD billion)
  • Table 46 Russia: Naltrexone And Buprenorphine Market, by Route of Administration, 2020-2034 (USD billion)
  • Table 47 Russia: Naltrexone And Buprenorphine Market, by Application, 2020-2034 (USD billion)
  • Table 48 Russia: Naltrexone And Buprenorphine Market, by Distribution Channel, 2020-2034 (USD billion)
  • Table 49 Rest of Europe: Naltrexone And Buprenorphine Market, by Product, 2020-2034 (USD billion)
  • Table 50 Rest of Europe: Naltrexone And Buprenorphine Market, by Route of Administration, 2020-2034 (USD billion)
  • Table 51 Rest of Europe: Naltrexone And Buprenorphine Market, by Application, 2020-2034 (USD billion)
  • Table 52 Rest of Europe: Naltrexone And Buprenorphine Market, by Distribution Channel, 2020-2034 (USD billion)
  • Table 53 Asia Pacific: Naltrexone And Buprenorphine Market, by Product, 2020-2034 (USD billion)
  • Table 54 Asia Pacific: Naltrexone And Buprenorphine Market, by Route of Administration, 2020-2034 (USD billion)
  • Table 55 Asia Pacific: Naltrexone And Buprenorphine Market, by Application, 2020-2034 (USD billion)
  • Table 56 Asia Pacific: Naltrexone And Buprenorphine Market, by Distribution Channel, 2020-2034 (USD billion)
  • Table 57 China: Naltrexone And Buprenorphine Market, by Product, 2020-2034 (USD billion)
  • Table 58 China: Naltrexone And Buprenorphine Market, by Route of Administration, 2020-2034 (USD billion)
  • Table 59 China: Naltrexone And Buprenorphine Market, by Application, 2020-2034 (USD billion)
  • Table 60 China: Naltrexone And Buprenorphine Market, by Distribution Channel, 2020-2034 (USD billion)
  • Table 61 India: Naltrexone And Buprenorphine Market, by Product, 2020-2034 (USD billion)
  • Table 62 India: Naltrexone And Buprenorphine Market, by Route of Administration, 2020-2034 (USD billion)
  • Table 63 India: Naltrexone And Buprenorphine Market, by Application, 2020-2034 (USD billion)
  • Table 64 India: Naltrexone And Buprenorphine Market, by Distribution Channel, 2020-2034 (USD billion)
  • Table 65 Malaysia: Naltrexone And Buprenorphine Market, by Product, 2020-2034 (USD billion)
  • Table 66 Malaysia: Naltrexone And Buprenorphine Market, by Route of Administration, 2020-2034 (USD billion)
  • Table 67 Malaysia: Naltrexone And Buprenorphine Market, by Application, 2020-2034 (USD billion)
  • Table 68 Malaysia: Naltrexone And Buprenorphine Market, by Distribution Channel, 2020-2034 (USD billion)
  • Table 69 Japan: Naltrexone And Buprenorphine Market, by Product, 2020-2034 (USD billion)
  • Table 70 Japan: Naltrexone And Buprenorphine Market, by Route of Administration, 2020-2034 (USD billion)
  • Table 71 Japan: Naltrexone And Buprenorphine Market, by Application, 2020-2034 (USD billion)
  • Table 72 Japan: Naltrexone And Buprenorphine Market, by Distribution Channel, 2020-2034 (USD billion)
  • Table 73 Indonesia: Naltrexone And Buprenorphine Market, by Product, 2020-2034 (USD billion)
  • Table 74 Indonesia: Naltrexone And Buprenorphine Market, by Route of Administration, 2020-2034 (USD billion)
  • Table 75 Indonesia: Naltrexone And Buprenorphine Market, by Application, 2020-2034 (USD billion)
  • Table 76 Indonesia: Naltrexone And Buprenorphine Market, by Distribution Channel, 2020-2034 (USD billion)
  • Table 77 South Korea: Naltrexone And Buprenorphine Market, by Product, 2020-2034 (USD billion)
  • Table 78 South Korea: Naltrexone And Buprenorphine Market, by Route of Administration, 2020-2034 (USD billion)
  • Table 79 South Korea: Naltrexone And Buprenorphine Market, by Application, 2020-2034 (USD billion)
  • Table 80 South Korea: Naltrexone And Buprenorphine Market, by Distribution Channel, 2020-2034 (USD billion)
  • Table 81 Australia: Naltrexone And Buprenorphine Market, by Product, 2020-2034 (USD billion)
  • Table 82 Australia: Naltrexone And Buprenorphine Market, by Route of Administration, 2020-2034 (USD billion)
  • Table 83 Australia: Naltrexone And Buprenorphine Market, by Application, 2020-2034 (USD billion)
  • Table 84 Australia: Naltrexone And Buprenorphine Market, by Distribution Channel, 2020-2034 (USD billion)
  • Table 85 Rest of Asia Pacific: Naltrexone And Buprenorphine Market, by Product, 2020-2034 (USD billion)
  • Table 86 Rest of Asia Pacific: Naltrexone And Buprenorphine Market, by Route of Administration, 2020-2034 (USD billion)
  • Table 87 Rest of Asia Pacific: Naltrexone And Buprenorphine Market, by Application, 2020-2034 (USD billion)
  • Table 88 Rest of Asia Pacific: Naltrexone And Buprenorphine Market, by Distribution Channel, 2020-2034 (USD billion)
  • Table 89 Middle East & Africa: Naltrexone And Buprenorphine Market, by Product, 2020-2034 (USD billion)
  • Table 90 Middle East & Africa: Naltrexone And Buprenorphine Market, by Route of Administration, 2020-2034 (USD billion)
  • Table 91 Middle East & Africa: Naltrexone And Buprenorphine Market, by Application, 2020-2034 (USD billion)
  • Table 92 Middle East & Africa: Naltrexone And Buprenorphine Market, by Distribution Channel, 2020-2034 (USD billion)
  • Table 93 Saudi Arabia: Naltrexone And Buprenorphine Market, by Product, 2020-2034 (USD billion)
  • Table 94 Saudi Arabia: Naltrexone And Buprenorphine Market, by Route of Administration, 2020-2034 (USD billion)
  • Table 95 Saudi Arabia: Naltrexone And Buprenorphine Market, by Application, 2020-2034 (USD billion)
  • Table 96 Saudi Arabia: Naltrexone And Buprenorphine Market, by Distribution Channel, 2020-2034 (USD billion)
  • Table 97 UAE: Naltrexone And Buprenorphine Market, by Product, 2020-2034 (USD billion)
  • Table 98 UAE: Naltrexone And Buprenorphine Market, by Route of Administration, 2020-2034 (USD billion)
  • Table 99 UAE: Naltrexone And Buprenorphine Market, by Application, 2020-2034 (USD billion)
  • Table 100 UAE: Naltrexone And Buprenorphine Market, by Distribution Channel, 2020-2034 (USD billion)
  • Table 101 Israel: Naltrexone And Buprenorphine Market, by Product, 2020-2034 (USD billion)
  • Table 102 Israel: Naltrexone And Buprenorphine Market, by Route of Administration, 2020-2034 (USD billion)
  • Table 103 Israel: Naltrexone And Buprenorphine Market, by Application, 2020-2034 (USD billion)
  • Table 104 Israel: Naltrexone And Buprenorphine Market, by Distribution Channel, 2020-2034 (USD billion)
  • Table 105 South Africa: Naltrexone And Buprenorphine Market, by Product, 2020-2034 (USD billion)
  • Table 106 South Africa: Naltrexone And Buprenorphine Market, by Route of Administration, 2020-2034 (USD billion)
  • Table 107 South Africa: Naltrexone And Buprenorphine Market, by Application, 2020-2034 (USD billion)
  • Table 108 South Africa: Naltrexone And Buprenorphine Market, by Distribution Channel, 2020-2034 (USD billion)
  • Table 109 Rest of Middle East & Africa: Naltrexone And Buprenorphine Market, by Product, 2020-2034 (USD billion)
  • Table 110 Rest of Middle East & Africa: Naltrexone And Buprenorphine Market, by Route of Administration, 2020-2034 (USD billion)
  • Table 111 Rest of Middle East & Africa: Naltrexone And Buprenorphine Market, by Application, 2020-2034 (USD billion)
  • Table 112 Rest of Middle East & Africa: Naltrexone And Buprenorphine Market, by Distribution Channel, 2020-2034 (USD billion)
  • Table 113 Latin America: Naltrexone And Buprenorphine Market, by Product, 2020-2034 (USD billion)
  • Table 114 Latin America: Naltrexone And Buprenorphine Market, by Route of Administration, 2020-2034 (USD billion)
  • Table 115 Latin America: Naltrexone And Buprenorphine Market, by Application, 2020-2034 (USD billion)
  • Table 116 Latin America: Naltrexone And Buprenorphine Market, by Distribution Channel, 2020-2034 (USD billion)
  • Table 117 Mexico: Naltrexone And Buprenorphine Market, by Product, 2020-2034 (USD billion)
  • Table 118 Mexico: Naltrexone And Buprenorphine Market, by Route of Administration, 2020-2034 (USD billion)
  • Table 119 Mexico: Naltrexone And Buprenorphine Market, by Application, 2020-2034 (USD billion)
  • Table 120 Mexico: Naltrexone And Buprenorphine Market, by Distribution Channel, 2020-2034 (USD billion)
  • Table 121 Brazil: Naltrexone And Buprenorphine Market, by Product, 2020-2034 (USD billion)
  • Table 122 Brazil: Naltrexone And Buprenorphine Market, by Route of Administration, 2020-2034 (USD billion)
  • Table 123 Brazil: Naltrexone And Buprenorphine Market, by Application, 2020-2034 (USD billion)
  • Table 124 Brazil: Naltrexone And Buprenorphine Market, by Distribution Channel, 2020-2034 (USD billion)
  • Table 125 Argentina: Naltrexone And Buprenorphine Market, by Product, 2020-2034 (USD billion)
  • Table 126 Argentina: Naltrexone And Buprenorphine Market, by Route of Administration, 2020-2034 (USD billion)
  • Table 127 Argentina: Naltrexone And Buprenorphine Market, by Application, 2020-2034 (USD billion)
  • Table 128 Argentina: Naltrexone And Buprenorphine Market, by Distribution Channel, 2020-2034 (USD billion)
  • Table 129 Rest of Latin America: Naltrexone And Buprenorphine Market, by Product, 2020-2034 (USD billion)
  • Table 130 Rest of Latin America: Naltrexone And Buprenorphine Market, by Route of Administration, 2020-2034 (USD billion)
  • Table 131 Rest of Latin America: Naltrexone And Buprenorphine Market, by Application, 2020-2034 (USD billion)
  • Table 132 Rest of Latin America: Naltrexone And Buprenorphine Market, by Distribution Channel, 2020-2034 (USD billion)

List of Figures:

  • Figure 1. Global Naltrexone And Buprenorphine Market, 2020-2034 (USD billion)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Price
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Product
  • Figure 7. Global Naltrexone And Buprenorphine Market, by Product, 2024 & 2034 (USD billion)
  • Figure 8. Market by Route of Administration
  • Figure 9. Global Naltrexone And Buprenorphine Market, by Route of Administration, 2024 & 2034 (USD billion)
  • Figure 10. Market by Application
  • Figure 11. Global Naltrexone And Buprenorphine Market, by Application, 2024 & 2034 (USD billion)
  • Figure 12. Market by Distribution Channel
  • Figure 13. Global Naltrexone And Buprenorphine Market, by Distribution Channel, 2024 & 2034 (USD billion)
  • Figure 14. Global Naltrexone And Buprenorphine Market Assessment, By Geography, 2020-2034 (USD billion)
  • Figure 15. Strategic Analysis - Global Naltrexone And Buprenorphine Market